These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11557358)

  • 1. 2-Alkynyl-8-aryladenines possessing an amide moiety: their synthesis and structure-activity relationships of effects on hepatic glucose production induced via agonism of the A(2B) adenosine receptor.
    Harada H; Asano O; Kawata T; Inoue T; Horizoe T; Yasuda N; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S
    Bioorg Med Chem; 2001 Oct; 9(10):2709-26. PubMed ID: 11557358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
    Harada H; Asano O; Hoshino Y; Yoshikawa S; Matsukura M; Kabasawa Y; Niijima J; Kotake Y; Watanabe N; Kawata T; Inoue T; Horizoe T; Yasuda N; Minami H; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S
    J Med Chem; 2001 Jan; 44(2):170-9. PubMed ID: 11170626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
    Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.
    Volpini R; Costanzi S; Lambertucci C; Vittori S; Cristalli G
    Curr Pharm Des; 2002; 8(26):2285-98. PubMed ID: 12369946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry and pharmacology of A2B adenosine receptors.
    Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN
    Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Linden J; Thai T; Figler H; Jin X; Robeva AS
    Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
    Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA
    J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.
    Areias F; Correia C; Rocha A; Teixeira S; Castro M; Brea J; Hu H; Carlsson J; Loza MI; Proença MF; Carvalho MA
    Molecules; 2024 May; 29(11):. PubMed ID: 38893418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2.
    Schulte G; Fredholm BB
    Mol Pharmacol; 2000 Sep; 58(3):477-82. PubMed ID: 10953039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes.
    Yasuda N; Inoue T; Horizoe T; Nagata K; Minami H; Kawata T; Hoshino Y; Harada H; Yoshikawa S; Asano O; Nagaoka J; Murakami M; Abe S; Kobayashi S; Tanaka I
    Eur J Pharmacol; 2003 Jan; 459(2-3):159-66. PubMed ID: 12524141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA
    J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones.
    Drabczyńska A; Müller CE; Lacher SK; Schumacher B; Karolak-Wojciechowska J; Nasal A; Kawczak P; Yuzlenko O; Pekala E; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 Nov; 14(21):7258-81. PubMed ID: 16844379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
    Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
    J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Minetti P; Tinti MO; Carminati P; Castorina M; Di Cesare MA; Di Serio S; Gallo G; Ghirardi O; Giorgi F; Giorgi L; Piersanti G; Bartoccini F; Tarzia G
    J Med Chem; 2005 Nov; 48(22):6887-96. PubMed ID: 16250647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.
    Klotz KN; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):629-34. PubMed ID: 12734636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.